This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nederf ors, T. Articles by Dahlof, C. Search for Related Content PubMed PubMed Citation Articles by Nederf ors, T. Articles by Dahlof, C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ATENOLOL PROPRANOLOL HYDROCHLORIDE Social Bookmarking                         What's this?

Effects of the β-adrenoceptor Antagonists Atenolol and Propranolol on Human Parotid and Submandibular-Sublingual Salivary Secretion

Department of Pharmacology and Clinical Pharmacology, Faculty of Odontology, University of Gothenburg, S-41345 Gothenburg, Sweden

T. Ericsson

Department of Cariology, University of Umea, Sweden

S. Twetman

Department of Pedodontics, Karolinska Institute, Huddinge, Sweden

C. Dahlof

Department of Pharmacology and Clinical Pharmacology, Faculty of Odontology, University of Gothenburg, S-41345 Gothenburg, Sweden

The aim of the study was to evaluate the effects of a β₁-selective (atenolol 50 mg q.d.) and a non-selective (propranolol 80 mg b.i.d.) p-adrenoceptor antagonist on human stimulated parotid and submandibular-sublingual (SM-SL) gland secretion. A randomized double-blind, placebo-controlled cross-over ("Latin square") design was used in 19 healthy male volunteers. Stimulated parotid and SM-SL saliva were sampled immediately before and 7 days after the start of each treatment period. Stimulation of salivary secretion was achieved by use of a 3% citric acid solution. Plasma concentrations of propranolol and atenolol were determined from blood samples. The salivary secretion of both glands was assessed for flow rate, amylase, lysozyme, and salivary peroxidase activity and for concentrations of total protein, hexosamine, sialic acid, Ca²⁺, Cl^-, K⁺, Mg²⁺, Na ⁺, and PO₄^3-. In both parotid and SM-SL secretions, the total protein and phosphate concentrations and amylase activity were significantly decreased during the two active treatment periods. In SM-SL gland secretion, there were significant changes in potassium and calcium concentrations during active treatment as compared with baseline, with potassium showing a decreased and calcium an increased concentration. During atenolol treatment, salivary peroxidase activity decreased significantly in SM-SL secretion. In parotid secretion, the hexosamine/total protein ratio decreased and the sialic acid/hexosamine ratio increased during atenolol treatment, which may indicate an effect on protein synthesis. No significant effects on salivary secretion rates were disclosed.

Key Words: (3-adrenergic Receptor Antagonists • Salivary Glands • Submandibular • Saliva.

Journal of Dental Research, Vol. 73, No. 1, 5-10 (1994)
DOI: 10.1177/00220345940730010701


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. Nederfors Xerostomia and Hyposalivation Advances in Dental Research, December 1, 2000; 14(1): 48 - 56. [Abstract] [PDF]

				J. Kivela, S. Parkkila, A.-K. Parkkila, J. Leinonen, and H. Rajaniemi Salivary carbonic anhydrase isoenzyme VI J. Physiol., October 15, 1999; 520(2): 315 - 320. [Abstract] [Full Text] [PDF]

				J.D. Rudney Does Variability in Salivary Protein Concentrations Influence Oral Microbial Ecology and Oral Health? Critical Reviews in Oral Biology & Medicine, January 1, 1995; 6(4): 343 - 367. [Abstract] [Full Text] [PDF]